Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sleep Number Corporation (SNBR) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Minnesota-based sleep wellness and wellness technology company in the upholstered household furniture manufacturing industry, Sleep Number uses these filings to report on its financial condition, capital structure, governance, and material events affecting the business.
Investors can review periodic reports such as Forms 10-Q and 10-K, which contain detailed financial statements, management’s discussion of results, and information about the company’s vertically integrated, exclusive direct-to-consumer model for selling smart beds, mattresses, bases, bedding, pillows, and furniture. These reports also describe trends in net sales, margins, operating expenses, restructuring costs, and liquidity.
The filings page also highlights current reports on Form 8-K, where Sleep Number discloses material events. Recent 8-Ks have covered quarterly earnings releases, amendments to the company’s credit and security agreement, and leadership changes. For example, the company reported a Twelfth Amendment to its credit agreement that extends the maturity date, adjusts the revolving credit facility, revises leverage and liquidity covenants, and introduces a minimum EBITDA covenant and expanded addbacks in the consolidated EBITDA definition. Other 8-Ks have described interim and permanent chief financial officer appointments and board retirements.
Users interested in capital structure and covenant details can examine filings that explain leverage ratio thresholds, liquidity requirements, interest coverage ratios, and how consolidated EBITDA is calculated for covenant purposes. These documents provide insight into how Sleep Number is managing its turnaround, cost reductions, and compliance with revised covenants.
On Stock Titan, AI-powered tools summarize complex filings, highlight key terms, and help interpret items such as 10-K risk factors, 10-Q quarterly updates, and 8-K covenant amendments. This allows readers to quickly understand the implications of Sleep Number’s SEC disclosures, including how changes in its credit agreement, restructuring activities, and leadership transitions may affect the company’s financial flexibility and strategic plans.
Sleep Number Corp EVP & Chief H.R. Officer Christopher D. Krusmark reported equity compensation and related tax withholding in company stock. On 3/16/26, he received a grant or award of 33,483 shares of Common Stock at no stated purchase price, increasing his direct holdings. The same day, 3,166 shares were disposed of at $3.45 per share to cover estimated tax obligations tied to vesting, a non‑market transaction. After these entries, he directly holds 80,961 shares of Common Stock and indirectly holds 2,402.9836 shares through a 401(k) plan. A footnote also notes 50,464 restricted stock units that are scheduled to vest over time, indicating additional potential future share delivery as vesting conditions are met.
Sleep Number Corp senior vice president and Chief Supply Chain officer Tanya C. Skogerboe reported compensation-related stock activity. She received a grant or award of 22,322 shares of common stock at no cost, increasing her direct holdings.
On the same date, 3,547 shares were withheld at $3.45 per share to cover estimated tax obligations tied to the vesting of 10,876 restricted shares, a non-market, tax-withholding disposition rather than an open-market sale. After these transactions, she directly holds 66,652 common shares and indirectly holds 2,517.4642 shares through a 401(k), and her position also includes 45,086 restricted stock units that will vest over time.
O'Keefe Amy K reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp reported that EVP & Chief Financial Officer Amy K. O'Keefe received a grant of 66,965 shares of common stock as a stock award, with no cash paid per share. After this award, she holds 136,707 restricted stock units that will vest over time, increasing her equity-based compensation stake but not involving any open-market buying or selling.
Sleep Number Corporation furnished an investor presentation outlining a comprehensive turnaround and financial stabilization plan. The company reported 2025 net sales of $1.41 billion and adjusted EBITDA of $78.3 million, with an adjusted EBITDA margin of 5.5%, alongside a net loss of $132.0 million and free cash flow of $(17.7) million.
Management highlighted more than $185 million of annualized cost reductions already executed and plans for an additional $50 million of annualized cost actions in 2026, supporting a pro forma adjusted EBITDA margin of about 9.1%. The strategy centers on three “Sleep Number Shifts”: simplifying the product portfolio, modernizing marketing to improve return on investment, and expanding distribution across physical and digital channels.
The company is also addressing liquidity and capital structure, citing an amended and extended credit agreement and a net leverage ratio of 4.1x under its revolving credit facility as of year-end 2025. Leadership expects that a stabilized top line, consistent gross margins, and a lower fixed cost base can support a return to free cash flow generation in 2026.
Sleep Number Corporation reports a difficult 2025 and describes an aggressive turnaround while warning of substantial doubt about its ability to continue as a going concern. Net sales fell 16%, producing a $132 million net loss. Adjusted EBITDA was $78 million, a 5.5% margin, down 1.6 percentage points.
Management cut operating costs by $136 million in 2025, extending cumulative reductions to $308 million over three years and amended its credit agreement, now maturing in December 2027. Even so, the company expects to breach financial covenants and may lack liquidity without new capital, lender concessions and successful execution of its “Sleep Number Shifts” turnaround.
Sleep Number Corporation appointed Kelly F. Baker as Controller and Principal Accounting Officer, effective March 11, 2026. She had been serving in this role on an interim basis since July 21, 2025, and has been the Company’s Controller since February 2025.
Baker, 41, previously served as Controller at Miromatrix Medical, Inc. and held finance roles at Donaldson Company, The Tile Shop, and Virtual Radiologic Corporation. She began her career at PricewaterhouseCoopers, holds both bachelor’s and MBA degrees, and is a Certified Public Accountant. The Company states there are no related‑party transactions requiring disclosure.
Sleep Number Corporation reported a difficult 2025 with early signs of a turnaround. Full-year net sales were $1.41 billion, down 16%, as weak industry demand and lower store traffic weighed on results. The company posted a net loss of $132 million, much wider than the prior year’s $20 million loss, while adjusted EBITDA fell 35% to $78 million with a 5.5% margin, down 160 basis points.
Despite this, Sleep Number realized $185 million of annualized cost savings and exited the year with a pro forma adjusted EBITDA margin of about 9%. Management plans another $50 million of annualized fixed cost reductions in 2026 and highlights strong initial demand and higher margins for its new ComfortMode bed and broader product refresh.
Liquidity remains tight, with net cash used in operating activities of $3 million, free cash flow of negative $18 million, cash of $1.7 million, and borrowings of $588.2 million under its revolving credit facility. The leverage ratio under the credit agreement was 4.1x EBITDAR versus a 4.5x covenant maximum, and the company has engaged Guggenheim Securities to evaluate options to improve its capital structure.
Pacific Ridge Capital Partners, LLC filed a Schedule 13G reporting beneficial ownership of 1,145,612 shares of Sleep Number Corp common stock, representing 5.0% of the outstanding class as of the event date.
Pacific Ridge reports sole voting power over 704,330 shares and sole dispositive power over all 1,145,612 shares, with no shared voting or dispositive power. It certifies the Sleep Number shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
FMR LLC has filed a Schedule 13G reporting beneficial ownership of 2,129,875.54 shares of Sleep Number Corp common stock, representing 9.3% of the outstanding class as of the event date. The filing also attributes the same 2,129,875.54 shares and 9.3% interest to Abigail P. Johnson, with sole dispositive power but no voting or shared dispositive power reported for her. FMR LLC reports sole voting power over 2,125,213 shares and confirms the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Sleep Number.
Sleep Number Corporation entered into a three-year brand deal with Travis Kelce and TMK Enterprises LLC. The Athlete Parties will work with the company to promote the benefits of quality sleep and help expand its market reach.
Compensation to the Athlete Parties will include cash and a restricted stock unit award granted under Sleep Number’s 2020 Equity Incentive Plan, with vesting over three years. They also agreed to make open market purchases of Sleep Number common stock, aligning part of their interests with existing shareholders.